Colorectal cancer surveillance after index colonoscopy: Guidance from the canadian association of gastroenterology

Canadian Journal of Gastroenterology

Volumn 27, Issue 4, 2013, Pages 224-228

  Leddin, Desmond ^a   Enns, Robert ^b   Hilsden, Robert ^c   Fallone, Carlo A ^d   Rabeneck, Linda ^e   Sadowski, Daniel C ^f   Singh, Harminder ^g  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY OF ALBERTA   (Canada)

^g UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Canada; Colonoscopy; Colorectal cancer; Guideline; Surveillance

Indexed keywords

ADENOMATOUS POLYP; ARTICLE; CANCER EPIDEMIOLOGY; COLONOSCOPY; COLORECTAL CANCER; ETHNICITY; FAMILY HISTORY; FOLLOW UP; INTESTINE PREPARATION; LIFESTYLE; OCCULT BLOOD TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 84876277858     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2013/232769     Document Type: Article

References (22)

1. van Kooten H, de Jonge V, Schreuders E, et al. Awareness of postpolypectomy surveillance guidelines: A nationwide survey of colonoscopists in Canada. Can J Gastroenterol 2012;26:79-84.
2. Leddin D, Armstrong D, Barkun AN, et al. Access to specialist gastroenterology care in Canada: Comparison of wait times and consensus targets. Can J Gastroenterol 2008;22:161-7.
3. Leddin D, Bridges RJ, Morgan DG, et al. Survey of access to gastroenterology in Canada: The SAGE wait times program. Can J Gastroenterol 2010;24:20-5.
4. Leddin D, Armstrong D, Borgaonkar M, et al. The 2012 SAGE wait times program: Survey of access to gastroenterology in Canada. Can J Gastroenterol 2013;27:83-9.
5. Lieberman DA, Rex DK, Winawer SJ, et al. Guidelines for colonoscopy surveillance after screening and polypectomy: A consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 2012;143:844-57.
6. Cairns SR, Scholefield JH, Steele RJ, et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 2010;59:666-89.
7. Segnan N, Patnick J, von Karsa L. European guidelines for quality assurance in colorectal cancer screening and diagnosis. Office for official publications of the European Communities. (Accessed January 25, 2013).
8. Leddin DJ, Enns R, Hilsden R, et al. Canadian Association of Gastroenterology position statement on screening individuals at average risk for developing colorectal cancer: 2010. Can J Gastroenterol 2010;24:705-14.
9. Armstrong D, Barkun A, Bridges R, et al. Canadian Association of Gastroenterology consensus guidelines on safety and quality indicators in endoscopy. Can J Gastroenterol 2012;26:17-31.
10. Wilschut JA, Habbema JD, Ramsey SD, et al. Increased risk of adenomas in individuals with a family history of colorectal cancer: Results of a meta-analysis. Cancer Causes Control 2010;21:2287-93.
11. Imperiale TF, Ransohoff DF. Risk for colorectal cancer in persons with a family history of adenomatous polyps: A systematic review. Ann Intern Med 2012;156:703-9.
12. Leddin D, Hunt R, Champion M, et al. Canadian Association of Gastroenterology and the Canadian Digestive Health Foundation: Guidelines on colon cancer screening. Can J Gastroenterol 2004;18:93-9.
13. Brenner H, Haug U, Arndt V, et al. Low risk of colorectal cancer and advanced adenomas more than 10 years after negative colonoscopy. Gastroenterology 2010;138:870-6.
14. Brenner H, Chang-Claude J, Seiler CM, Hoffmeister M. Long-term risk of colorectal cancer after negative colonoscopy. J Clin Oncol 2011;29:3761-7.
15. Rex DK, Ahnen DJ, Baron JA, et al. Serrated lesions of the colorectum: Review and recommendations from an expert panel. Am J Gastroenterol 2012;107:1315-29.
16. Snover D, Ahnen D, Burt R, Odze R. Serrated polyps of the colon and rectum and serrated polyposis. In: Bosman F, Carneiro F, Hruban R, et al, eds. WHO Classification of tumours of the digestive system. Lyon: IARC; 2010.
17. Singh H, Bay D, Ip S, et al. Pathological reassessment of hyperplastic colon polyps in a city-wide pathology practice: Implications for polyp surveillance recommendations. Gastrointest Endosc 2012;76:1003-8.
18. Warren JL, Klabunde CN, Mariotto AB, et al. Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med 2009;150:849-57, W152.
19. Saini SD, Nayak RS, Kuhn L, Schoenfeld P. Why don't gastroenterologists follow colon polyp surveillance guidelines?: Results of a national survey. J Clin Gastroenterol 2009;43:554-8.
20. John BJ, Irukulla S, Pilgrim G, Swift I, Abulafi AM. Surveillance colonoscopies for colorectal polyps - too often, too many! An audit at a large district general hospital. Colorectal Dis 2008;10:898-900.
21. O'Connor A, Keane RA, Egan B, et al. Adherence to colorectal polyp surveillance guidelines: Is there a 'scope' to increase the opportunities for screening? Eur J Cancer Prev 2011;20:40-5.
22. Driman D, Marcus V, Hilsden R, Owen D. Pathological reporting of colorectal polyps: Pan-Canadian consensus guidelines. Can J Pathology 2012;4:81-90.